Clinical Trial Update: A Study in Healthy Participants Investigating the Effect of TMC435 on the Pharmacokinetics of Immunosuppressants Cyclosporine and Tacrolimus [Phase 1]

View source ↗

Summary

A Phase 1 study in healthy participants assessed the effect of TMC435 on the pharmacokinetics of cyclosporine and tacrolimus. The trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• TMC435
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Tibotec Pharmaceuticals, Ireland | Conditions: Hepatitis C Virus | Phase 1 | Status: COMPLETED